Union Bank of India rises as domestic advances grow 10% YoY in Q4 FY26

Mumbai, April 6 -- Domestic deposits grew 2.72% YoY to Rs 13,06,297 crore, while rising 6.88% QoQ as of 31 March 2026. Domestic CASA deposits stood at Rs 4,59,988 crore, increasing 7.90% YoY and 10.82... Read More

8 years on, construction on Narsingdi Hospital's new building remains incomplete

Dhaka, April 6 -- The construction of a new building for the 100-bed district hospital in Narsingdi has not been completed in eight years. Meanwhile, patient services are being disrupted due to lack o... Read More

Tata Group Stock Skyrockets 8% After Its Revenue Increases 20% YoY

India, April 6 -- This Tata Group retail player is in focus as its shares surged 8 percent in today's session, outperforming the broader market after reporting a strong Q4 business update. The rally c... Read More

Bank of Baroda gains as global advances grow 16% YoY in Q4 FY26

Mumbai, April 6 -- The bank's global business stood at Rs 30,78,854 crore, registering a growth of 13.93% YoY compared to Rs 27,02,496 crore as of 31 March 2025. Global deposits increased 12.00% YoY t... Read More

Goldiam Int. opens ORIGEM stores at Hyderabad and Bangalore

Mumbai, April 6 -- Goldiam International has opened its 22nd and 23rd retail stores for lab-grown diamond jewellery under the brand name "ORIGEM" at the following locations, which commenced operation... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

• ««
• «
• 851
• 852
• 853
• 854
• 855
• 856
• 857
• 858
• 859
• 860
• »
• »»